Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-08-001816
Filing Date
2008-03-17
Accepted
2008-03-17 12:00:33
Documents
10
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 EPIX PHARMACEUTICALS, INC. FORM 10-K b68133epe10vk.htm 10-K 1109699
2 EX-10.6 AMENDED AND RESTATED STRATEGIC COLLABORATION AGREEMENT DATED AS OF JUNE b68133epexv10w6.htm EX-10.6 143101
3 EX-10.7 STRATEGIC COLLABORATION AGREEMENT DATED AS OF JUNE 9, 2000 b68133epexv10w7.htm EX-10.7 314677
4 EX-10.8 AMENDMENT NO. 1 DATED AS OF DECEMBER 22, 2000 TO THE STRATEGIC COLLABORA b68133epexv10w8.htm EX-10.8 10011
5 EX-12.1 RATIO OF EARNINGS TO FIXED CHARGES b68133epexv12w1.htm EX-12.1 14218
6 EX-23.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM b68133epexv23w1.htm EX-23.1 2463
7 EX-31.1 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 b68133epexv31w1.htm EX-31.1 6410
8 EX-31.2 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 b68133epexv31w2.htm EX-31.2 6591
9 EX-32 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (S b68133epexv32.htm EX-32 3786
10 GRAPHIC b68133epb6813301.gif GRAPHIC 45211
  Complete submission text file 0000950135-08-001816.txt   1674848
Mailing Address 4 MAGUIRE ROAD LEXINGTON MA 02421
Business Address 4 MAGUIRE ROAD LEXINGTON MA 02421 6172506000
EPIX Pharmaceuticals, Inc. (Filer) CIK: 0001027702 (see all company filings)

EIN.: 043030815 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21863 | Film No.: 08691774
SIC: 2834 Pharmaceutical Preparations